The Burden of Thalassemia and Various Hemoglobinopathiesin Bihar: Trends and Patterns
Main Article Content
Keywords
β-thalassemia trait, hemoglobinopathies, high-performance liquid chromatography, screening, prevalence, Indian population
Abstract
Background: In India, the carrier frequency of the β-thalassemia trait (βTT) is substantially higher than the global average, estimated at 3.3% compared with 1.5% worldwide. The prevalence of βTT across India shows marked geographic variation, ranging from 0.5% to 17%, largely influenced by population migration, endogamy, and inter-caste marriages. This genetic and demographic diversity makes India a complex conglomerate of multiple biological populations. The present study aimed to evaluate the spectrum of hemoglobinopathies and thalassemia in a region of Eastern India using cation-exchange high-performance liquid chromatography (CE-HPLC), while also analyzing associated demographic characteristics and hematological parameters.
Methodology: This was a two-year (June 2022–May 2024), single-center, retrospective observational study involving 2,329 subjects who were screened for thalassemia and other hemoglobinopathies using CE-HPLC at the Department of Hematology of a tertiary care center in Northern India.
Results: Of the 2,329 subjects screened, 2,067 (88.7%) were diagnosed as normal, 167 (7.1%) had βTT, and 35 (1.5%) were double heterozygous for HbE and βTT. The mean red blood cell (RBC) count among individuals with βTT was 4.58 ± 1.11 million/cumm, the highest among all hemoglobinopathies except for two cases of HbD-Punjab trait, which demonstrated a mean RBC count of 4.62 ± 0.36 million/cumm. HbF fractions were highest in cases of β-thalassemia major/intermedia, followed by individuals with double heterozygous HbE and βTT. Categorical variables were expressed as percentages, while numerical variables were summarized as mean ± standard deviation (SD). Statistical analysis was performed using SPSS version 25.
Conclusion: This study underscores the high prevalence of β-thalassemia trait and other hemoglobinopathies in Eastern India, emphasizing the need for widespread screening programs and the adoption of improved diagnostic modalities.
References
2. World Health Organization and Thalassaemia International Federation. Management of haemoglobin disorders – report of Joint WHO‐TIF meeting 2007.
3. Sumedha D, Anita K. Prevalence of beta thalassemia carriers in India: a systematic review and meta-analysis. J Community Genet. 2023 Dec;14(6):527-541.
4. Yadav SS, Panchal P, Menon KC. Prevalence and Management of β-Thalassemia in India. Hemoglobin. 2022 Jan;46(1):27-32.
5. Sachdev R, Dam AR, Tyagi G. Detection of Hb variants and haemoglobinopathies in Indian population using HPLC: Report of 2600 cases. Indian J Pathol Microbiol 2010;53:57-62.
6. Yuanyuan T, Yang L, Yang L, Jianjuan M, Xiaoyan Y, Shasha W. Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021. The Lancet.2024:1-14.
7. Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β- thalassemias and hemoglobin E disorders. Expert Rev Hematol 2010;3:103-17.
8.Vaz FE, Thakur CB, Banerjee MK, Gangal SG. Distribution of beta-thalassemia mutations in the Indian population referred to a diagnostic center. Hemoglobin 2000;24:181-94.
9.Bravo-Urquuiola M, Arends A, Montilla S, Velasquez D, Garcia G, Alvarez M, et al. Advantages in the use of high performance chromatography technique for screening hemoglobinopathies in Venezuela. Invest Clin 2004;45:309-15.
10. Rao S, Kar R, Gupta SK, Chopra A, Saxena R. Spectrum of hemoglobinopathies diagnosed by cation exchange-HPLC and modulating effects of nutritional def ciency anaemias from north India. Indian J Med Res 2010;132:513-9.
11. Balgir RS. The burden of hemoglobinopathies in India and the challenges ahead. Curr Sci 2000;79:1536-47.
12. Mondal B, Maiti S, Biswas BK, Ghosh D, Paul S. Prevalence of hemoglobinopathy, ABO and rhesus blood groups in rural areas of West Bengal, India. J Res Med Sci 2012;17:772-6.
13. Madan N, Sharma S, Sood SK, Colah R, Bhatia LH. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet 2010;16:16-25.
14. Roshan Colah, Khushnooma Italia, Ajit Gorakshakar,Burden of thalassemia in India: The road map for control, Pediatric Hematology Oncology 2017:79-84,
15. Dolai TK, DuĴ a S, BhaĴ acharyya M, Ghosh MK. Prevalence of hemoglobinopathies in rural Bengal, India. Hemoglobin 2012; 36:57-63.
16.Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci. 2016 Jan-Jun;10(1):105-10.
17. Saha, S., Ghosh, S., Basu, K. et al. Prevalence of β-haemoglobinopathies in Eastern India and development of a novel formula for carrier detection. J Hematopathol 2020: 159–164 .
18. Nagar R, Sinha S, Raman R. Haemoglobinopathies in eastern Indian states: a demographic evaluation. J Community Genet. 2015 Jan;6(1):1-8.
19. Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: A multicentre study. J Community Genet 2013;4:33-42.
20. Jain BB, Roy RN, Ghosh S, Ghosh T, Banerjee U, Bhattacharya SK (2012) Screening for thalassemia and other hemoglobinopathies in a tertiary care hospital of West Bengal: implications for population screening. Indian J Public Health 56:297–3009.
21. Kattamis A, Forni GL, Aydinok Y, Viprakasit V. Changing patterns in the epidemiology of β- thalassemia. Eur J Haematol. 2020 Dec;105(6):692-703.
22. Manna AK, DuĴ a SK, ChaĴ erjee A. Relative incidence of different thalassaemias and haemoglobinopathies in South Bengal. J Indian Med Assoc 2009;107:347-9.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.